ScholarIQanswers from OpenAlex & ORCID
Henk M.W. Verheul
ResearcherPublications, citations & collaboration network
Henk M.W. Verheul is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Henk M.W. Verheul have?
ScholarIQindexed works
Henk M.W. Verheul has 957 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Henk M.W. Verheul have?
ScholarIQcitation count
Henk M.W. Verheul has 30,077 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Henk M.W. Verheul?
ScholarIQh-index
Henk M.W. Verheul has an h-index of 75 in OpenAlex.
What is the i10-index of Henk M.W. Verheul?
ScholarIQi10-index
Henk M.W. Verheul has an i10-index of 352 in OpenAlex.
What is the ORCID of Henk M.W. Verheul?
ScholarIQorcid
The ORCID for Henk M.W. Verheul is on the source record.
What is the OpenAlex record for Henk M.W. Verheul?
ScholarIQopenalex
The OpenAlex for Henk M.W. Verheul is on the source record.
What are the most-cited papers on Henk M.W. Verheul?
ScholarIQmost cited works
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
Pieter van Hagen, Maarten C.C.M. Hulshof, J. Jan B. van Lanschot, Ewout W. Steyerberg, Mark I. van Berge Henegouwen, Bas P. L. Wijnhoven, Dick J. Richel, Grard A. P. Nieuwenhuijzen, Geke A.P. Hospers, Johannes J. Bonenkamp, Miguel A. Cuesta, R.J.B. Blaisse, Olivier R. Busch, F.J.W. ten Kate, G.J. Creemers, C.J.A. Punt, John Theodorus Plukker, Henk M.W. Verheul, Ernst Jan Spillenaar Bilgen, Herman van Dekken, Maurice J.C. van der Sangen, Tom Rozema, Katharina Biermann, Jannet C. Beukema, Anna H.M. Piet, Caroline M. van Rij, Janny G. Reinders, H.W. Tilanus, Ate van der Gaast
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
Joël Shapiro, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof, Pieter van Hagen, Mark I. van Berge Henegouwen, Bas P. L. Wijnhoven, Hanneke W.M. van Laarhoven, Grard A. P. Nieuwenhuijzen, Geke A.P. Hospers, Johannes J. Bonenkamp, Miguel A. Cuesta, R.J.B. Blaisse, Olivier R. Busch, Fiebo J.W. ten Kate, Geert-Jan Creemers, Cornelis J.A. Punt, John Th. M. Plukker, Henk M.W. Verheul, Ernst Jan Spillenaar Bilgen, Herman van Dekken, Maurice J.C. van der Sangen, Tom Rozema, Katharina Biermann, Jannet C. Beukema, Anna H.M. Piet, Caroline M. van Rij, Janny G. Reinders, Hugo W. Tilanus, Ewout W. Steyerberg, Ate van der Gaast
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
Ben M. Eyck, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof, Berend J. van der Wilk, Joël Shapiro, Pieter van Hagen, Mark I. van Berge Henegouwen, Bas P. L. Wijnhoven, Hanneke W. M. van Laarhoven, Grard A. P. Nieuwenhuijzen, Geke A.P. Hospers, Johannes J. Bonenkamp, Miguel A. Cuesta, R.J.B. Blaisse, Olivier R. Busch, Geert-Jan Creemers, Cornelis J.A. Punt, John Th. M. Plukker, Henk M.W. Verheul, Ernst Jan Spillenaar Bilgen, Maurice J.C. van der Sangen, Tom Rozema, Fiebo J.W. ten Kate, Jannet C. Beukema, Anna H.M. Piet, Caroline M. van Rij, Janny G. Reinders, Hugo W. Tilanus, Ewout W. Steyerberg, Ate van der Gaast, for the CROSS Study Group
MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity
Elisa Giovannetti, Niccola Funel, Godefridus J. Peters, Marco Del Chiaro, Leyla A. Erozenci, Enrico Vasile, Leticia G. León, Luca Emanuele Pollina, Annemieke Groen, Alfredo Falcone, Romano Danesi, Daniela Campani, Henk M.W. Verheul, Ugo Boggi